Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.

PubWeight™: 3.72‹?› | Rank: Top 1%

🔗 View Article (PMC 2662988)

Published in Am J Respir Crit Care Med on September 15, 2005

Authors

Moises Selman1, Annie Pardo, Lourdes Barrera, Andrea Estrada, Susan R Watson, Keith Wilson, Natasha Aziz, Naftali Kaminski, Albert Zlotnik

Author Affiliations

1: Neurocrine Biosciences, 12790 El Camino Real, San Diego, CA 92130, USA.

Articles citing this

(truncated to the top 100)

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest (2009) 3.33

Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32

Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov (2010) 3.20

Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS One (2008) 2.94

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med (2006) 2.92

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med (2008) 2.79

Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A (2010) 2.66

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med (2008) 2.41

Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc (2006) 2.40

WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol (2009) 2.36

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One (2007) 1.88

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One (2011) 1.87

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.64

Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheumatol (2014) 1.58

Rheumatoid lung disease. Proc Am Thorac Soc (2007) 1.55

Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum (2011) 1.51

Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem (2012) 1.47

Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 1.47

Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med (2007) 1.46

Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol (2011) 1.44

Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One (2012) 1.44

Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One (2008) 1.30

Molecular staging of epithelial maturation using secretory cell-specific genes as markers. Am J Respir Cell Mol Biol (2008) 1.28

Clara cells attenuate the inflammatory response through regulation of macrophage behavior. Am J Respir Cell Mol Biol (2009) 1.24

Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc Am Thorac Soc (2006) 1.22

Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology (2009) 1.16

Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest (2013) 1.11

Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res (2006) 1.10

Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. Am J Respir Crit Care Med (2010) 1.08

Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.08

Human lung project: evaluating variance of gene expression in the human lung. Am J Respir Cell Mol Biol (2006) 1.07

A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol (2008) 1.07

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med (2011) 1.07

The role of postmortem studies in pneumonia etiology research. Clin Infect Dis (2012) 1.01

Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.01

Towards systems biology of human pulmonary fibrosis. Proc Am Thorac Soc (2007) 1.00

MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet (2008) 1.00

CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol (2012) 1.00

Transcriptomic studies of the airway field of injury associated with smoking-related lung disease. Proc Am Thorac Soc (2011) 0.99

Molecular biomarkers in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2014) 0.99

Role of matrix metaloproteases in idiopathic pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 0.97

Workshop on idiopathic pulmonary fibrosis in older adults. Chest (2010) 0.96

Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur Respir J (2008) 0.92

Interstitial lung disease: progress and problems. Postgrad Med J (2006) 0.91

Mechanisms of alveolar epithelial injury, repair, and fibrosis. Ann Am Thorac Soc (2015) 0.91

Wnt pathway in pulmonary fibrosis in the bleomycin mouse model. J Environ Pathol Toxicol Oncol (2009) 0.91

Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes. Clin Transl Sci (2011) 0.91

Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res (2009) 0.89

Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol (2007) 0.88

Epigenomics of idiopathic pulmonary fibrosis. Epigenomics (2012) 0.88

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res (2016) 0.87

Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics (2011) 0.86

MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum Genet (2009) 0.86

Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS One (2013) 0.85

Using mouse genomics to understand idiopathic interstitial fibrosis. Proc Am Thorac Soc (2007) 0.85

Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med (2016) 0.85

The Lipid Transfer Protein StarD7: Structure, Function, and Regulation. Int J Mol Sci (2013) 0.84

Personalized medicine: applying 'omics' to lung fibrosis. Biomark Med (2012) 0.84

Epigenetics of idiopathic pulmonary fibrosis. Transl Res (2014) 0.83

The role of Toll-like receptors in age-associated lung diseases. J Gerontol A Biol Sci Med Sci (2012) 0.83

Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings. F1000Prime Rep (2014) 0.83

TLR2 regulates neutrophil recruitment and cytokine production with minor contributions from TLR9 during hypersensitivity pneumonitis. PLoS One (2013) 0.81

TLR9-dependent IL-23/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis. J Immunol (2012) 0.80

Translating translational research: mouse models of human disease. Cell Mol Immunol (2013) 0.80

Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med (2016) 0.79

Expression profiling in granulomatous lung disease. Proc Am Thorac Soc (2007) 0.79

Comparison of gene expression profiling between lung fibrotic and emphysematous tissues sampled from patients with combined pulmonary fibrosis and emphysema. Fibrogenesis Tissue Repair (2012) 0.79

Classification of interstitial pneumonias: what do gene expression profiles tell us? Am J Respir Crit Care Med (2006) 0.79

Epigenetics in lung fibrosis: from pathobiology to treatment perspective. Curr Opin Pulm Med (2015) 0.79

Recent advances in understanding idiopathic pulmonary fibrosis. F1000Res (2016) 0.78

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis. Fibrogenesis Tissue Repair (2015) 0.78

Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol (2016) 0.78

Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis. Sci Rep (2015) 0.77

MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy. Oncotarget (2016) 0.77

Idiopathic pulmonary fibrosis: the need for early diagnosis. Multidiscip Respir Med (2013) 0.77

Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosis. Am J Respir Cell Mol Biol (2008) 0.76

Increased alveolar soluble annexin V promotes lung inflammation and fibrosis. Eur Respir J (2015) 0.76

Flu and pulmonary fibrosis. Lung India (2013) 0.76

Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood. BMC Genomics (2014) 0.76

Intratracheal instillation of high dose adenoviral vectors is sufficient to induce lung injury and fibrosis in mice. PLoS One (2014) 0.76

Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis. Int J Mol Epidemiol Genet (2014) 0.76

Interleukin-17A and Neutrophils in a Murine Model of Bird-Related Hypersensitivity Pneumonitis. PLoS One (2015) 0.75

Reactive oxygen species-associated molecular signature predicts survival in patients with sepsis. Pulm Circ (2016) 0.75

IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER. Trans Am Clin Climatol Assoc (2016) 0.75

Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis. PLoS One (2016) 0.75

What is this thing called CFA? Thorax (2007) 0.75

Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases. Front Genet (2016) 0.75

Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases. J Transl Med (2015) 0.75

iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis. PLoS One (2017) 0.75

Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis. Diagn Pathol (2016) 0.75

Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis. BMC Pulm Med (2017) 0.75

Gene profile of fibroblasts identify relation of CCL8 with idiopathic pulmonary fibrosis. Respir Res (2017) 0.75

Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis. BMC Pulm Med (2017) 0.75

A blood test for lung fibrosis. PLoS Med (2008) 0.75

Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice. Environ Health Perspect (2016) 0.75

Protein antigen of bird-related hypersensitivity pneumonitis in pigeon serum and dropping. Respir Res (2017) 0.75

Macrophages and Fibrosis Resolution. Harnessing Wnt/β-Catenin Signaling as the Way and the Means. Am J Respir Cell Mol Biol (2017) 0.75

Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung Myofibroblasts. J Immunol (2015) 0.75

Articles cited by this

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med (2002) 19.02

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med (2000) 12.71

Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med (1998) 6.22

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88

T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol (2004) 5.53

Tissue classification with gene expression profiles. J Comput Biol (2000) 5.06

CCN proteins: multifunctional signalling regulators. Lancet (2004) 4.88

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 4.88

Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol (2000) 4.33

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A (2002) 4.00

Chemokines as regulators of T cell differentiation. Nat Immunol (2001) 3.37

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med (2005) 3.15

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63

Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol (2001) 2.51

Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol (1994) 2.37

A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08

Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol (2000) 2.07

Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest (2004) 1.95

Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol (2005) 1.91

Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J (2003) 1.84

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res (2003) 1.81

WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev (2002) 1.80

Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol (2002) 1.72

Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med (2001) 1.64

Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease. Am J Respir Crit Care Med (1998) 1.59

Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am J Respir Crit Care Med (2004) 1.59

Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol (2002) 1.55

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann Neurol (2004) 1.48

A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem (2003) 1.47

Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol (2003) 1.42

Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med (2000) 1.41

Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem (2002) 1.32

Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis (1993) 1.26

Keratinocytes from patients lacking collagen XVII display a migratory phenotype. Am J Pathol (2004) 1.20

Molecular mechanisms of pulmonary fibrosis. Front Biosci (2002) 1.17

Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol (1999) 1.16

Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology (1989) 1.13

Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.12

Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum (2004) 1.07

Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J Invest Dermatol (2000) 1.05

Gene expression in aggressive fibromatosis. J Lab Clin Med (2004) 1.05

Anchoring fibrils. A new connective tissue structure in fibrotic lung disease. Am J Pathol (1978) 1.05

Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab Invest (2005) 1.04

Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Respir Crit Care Med (1999) 1.00

Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med (2004) 0.98

Epitope-defined monoclonal antibodies against multiplexin collagens demonstrate that type XV and XVIII collagens are expressed in specialized basement membranes. Cell Struct Funct (2002) 0.96

Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest (2003) 0.95

Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif. Matrix Biol (2003) 0.93

Viral infection modulates expression of hypersensitivity pneumonitis. J Immunol (1999) 0.89

In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul (1993) 0.86

Specificity of WNT-receptor interactions. Front Biosci (2004) 0.85

Cytokine-binding proteins in the lung. Am J Physiol (1995) 0.82

Articles by these authors

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med (2002) 8.33

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A (2003) 7.41

Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71

Idiopathic pulmonary fibrosis. Lancet (2011) 5.25

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med (2007) 5.06

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med (2010) 4.71

From signatures to models: understanding cancer using microarrays. Nat Genet (2005) 4.29

Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature (2003) 4.02

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med (2002) 4.02

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A (2002) 4.00

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 3.42

Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest (2009) 3.42

Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics (2006) 3.40

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med (2005) 3.15

Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.02

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med (2006) 2.92

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med (2008) 2.79

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc (2006) 2.77

Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol (2002) 2.68

Silence of chromosomal amplifications in colon cancer. Cancer Res (2002) 2.58

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol (2008) 2.42

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci U S A (2004) 2.42

Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med (2008) 2.41

IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol (2006) 2.39

WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol (2009) 2.36

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov (2012) 2.31

Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS One (2009) 2.29

A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol (2015) 2.21

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA (2013) 2.20

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res (2001) 2.19

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol (2008) 2.17

Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol (2003) 2.14

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11

MicroRNAs in idiopathic pulmonary fibrosis. Transl Res (2011) 2.10

Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs (2004) 2.05

Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays. Bioinformatics (2004) 2.04

Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol (2010) 2.03

The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat Immunol (2008) 1.97

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest (2009) 1.96

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One (2007) 1.88

Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res (2002) 1.86

T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med (2009) 1.86

Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest (2015) 1.85

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med (2013) 1.81

A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med (2011) 1.81

Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med (2012) 1.79

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses. Am J Respir Crit Care Med (2013) 1.77

Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol (2005) 1.76

Human and porcine early kidney precursors as a new source for transplantation. Nat Med (2002) 1.73

Role of Sonic Hedgehog in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.71

Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med (2014) 1.69

Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem (2008) 1.69

Comparison of normalization methods for CodeLink Bioarray data. BMC Bioinformatics (2005) 1.65

Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.63

Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.61

Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci U S A (2007) 1.58

GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J Virol (2002) 1.58

Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.58

Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J (2005) 1.55

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54

An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics (2012) 1.54

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One (2010) 1.53

miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet (2013) 1.53

Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc Natl Acad Sci U S A (2007) 1.52

Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol (2004) 1.51

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann Neurol (2004) 1.48

A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors. Clin Cancer Res (2008) 1.47

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression. Eur Respir J (2013) 1.47

Gene expression profiling of target genes in ventilator-induced lung injury. Physiol Genomics (2006) 1.45

Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One (2012) 1.44

Open-access biorepository for idiopathic pulmonary fibrosis. The way forward. Ann Am Thorac Soc (2014) 1.42

Pillars article: a developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 1993. 150: 4244-4252. J Immunol (2012) 1.42

Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One (2008) 1.41

Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet (2003) 1.40

Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol (2007) 1.39

A clinical study of migraine evolution. Headache (2006) 1.39

Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Res (2006) 1.39

Describing Activity in Primary Percutaneous Coronary Intervention: An Exploration of Denominators. From the HEAT Trial - A Systematic Evaluation of PPCI Activations in Liverpool, Explaining Denominators (HEAT-SEALED). J Invasive Cardiol (2016) 1.37

CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol (2005) 1.37

MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis. Nucleic Acids Res (2011) 1.35

Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.30

Molecular staging of epithelial maturation using secretory cell-specific genes as markers. Am J Respir Cell Mol Biol (2008) 1.28

A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res (2005) 1.28

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One (2009) 1.28

Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis. Am J Pathol (2011) 1.27

The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol (2003) 1.25

Clara cells attenuate the inflammatory response through regulation of macrophage behavior. Am J Respir Cell Mol Biol (2009) 1.24

Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol (2007) 1.24